| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Faizan Mazhar, Shahzad Akram, Nafis Haider, Rafeeque Ahme. Overlapping of Serotonin Syndrome with Neuroleptic Malignant Syndrome due to Linezolid-Fluoxetine and Olanzapine-Metoclopramide Interactions: A Case Report of Two Serious Adverse Drug Effects Caused by Medication Reconciliation Failure on Hospital Admission. Case reports in medicine. vol 2016. 2016-07-19. PMID:27433163. |
the concomitant use of antipsychotic and/or antidepressant with drugs that may interact can lead to rare, life-threatening conditions such as serotonin syndrome and neuroleptic malignant syndrome. |
2016-07-19 |
2023-08-13 |
Not clear |
| Faizan Mazhar, Shahzad Akram, Nafis Haider, Rafeeque Ahme. Overlapping of Serotonin Syndrome with Neuroleptic Malignant Syndrome due to Linezolid-Fluoxetine and Olanzapine-Metoclopramide Interactions: A Case Report of Two Serious Adverse Drug Effects Caused by Medication Reconciliation Failure on Hospital Admission. Case reports in medicine. vol 2016. 2016-07-19. PMID:27433163. |
we describe a patient who has a history of taking two offending drugs that interact with drugs given during the course of hospital treatment which leads to the development of serotonin syndrome overlapped with neuroleptic malignant syndrome. |
2016-07-19 |
2023-08-13 |
Not clear |
| Chin-Pang Lee, Pei-Jung Chen, Chia-Ming Chan. Heat stroke during treatment with olanzapine, trihexyphenidyl, and trazodone in a patient with schizophrenia. Acta neuropsychiatrica. vol 27. issue 6. 2016-06-20. PMID:26503496. |
possible differential diagnoses of heat stroke in this case include infection, neuroleptic malignant syndrome, and serotonin syndrome. |
2016-06-20 |
2023-08-13 |
Not clear |
| A-L Pot, M Lejoyeu. [Catatonia]. L'Encephale. vol 41. issue 3. 2016-03-02. PMID:25858694. |
among the differential diagnoses, which are rare motor syndromes, neuroleptic malignant syndrome and serotonin syndrome are also discussed. |
2016-03-02 |
2023-08-13 |
Not clear |
| Kalliopi N Nikolaou, Rossetos Gournellis, Ioannis Michopoulos, Georgios Dervenoulas, Christos Christodoulou, Athanasios Douzeni. Neurotoxic syndrome induced by clomipramine plus risperidone in a patient with autistic spectrum disorder: serotonin or neuroleptic malignant syndrome? Annals of general psychiatry. vol 14. 2015-11-20. PMID:26583039. |
neurotoxic syndrome induced by clomipramine plus risperidone in a patient with autistic spectrum disorder: serotonin or neuroleptic malignant syndrome? |
2015-11-20 |
2023-08-13 |
Not clear |
| Kalliopi N Nikolaou, Rossetos Gournellis, Ioannis Michopoulos, Georgios Dervenoulas, Christos Christodoulou, Athanasios Douzeni. Neurotoxic syndrome induced by clomipramine plus risperidone in a patient with autistic spectrum disorder: serotonin or neuroleptic malignant syndrome? Annals of general psychiatry. vol 14. 2015-11-20. PMID:26583039. |
the diagnosis of serotonin syndrome was challenging due to the relatively low dose of clomipramine, an increase of risperidone which had taken place before clomipramine administration and clinical symptoms which could be attributed to both serotonin and neuroleptic malignant syndrome. |
2015-11-20 |
2023-08-13 |
Not clear |
| S Mohammad Moosavi, Mahshid Ahmadi, Mani B Monajem. Acute dystonia due to citalopram treatment: a case series. Global journal of health science. vol 6. issue 6. 2015-01-29. PMID:25363102. |
abnormal movements such as acute dystonia, dyskinesia, parkinsonism, exacerbation of parkinson disease, akathisia and possibly neuroleptic malignant syndrome may be associated with the use of selective serotonin reuptake inhibitors (ssris) rarely. |
2015-01-29 |
2023-08-13 |
Not clear |
| Rupal Dosi, Annirudh Ambaliya, Harshal Joshi, Rushad Patel. Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary. BMJ case reports. vol 2014. 2015-01-21. PMID:24957740. |
serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary. |
2015-01-21 |
2023-08-13 |
Not clear |
| Rupal Dosi, Annirudh Ambaliya, Harshal Joshi, Rushad Patel. Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary. BMJ case reports. vol 2014. 2015-01-21. PMID:24957740. |
serotonin syndrome and neuroleptic malignant syndrome are two drug toxidromes that have often overlapping and confusing clinical pictures. |
2015-01-21 |
2023-08-13 |
Not clear |
| Rupal Dosi, Annirudh Ambaliya, Harshal Joshi, Rushad Patel. Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary. BMJ case reports. vol 2014. 2015-01-21. PMID:24957740. |
the patient satisfied criteria for serotonin syndrome and neuroleptic malignant syndrome, and based on the characteristic clinical features, laboratory findings and clinical course it was concluded that the patient had both toxidromes. |
2015-01-21 |
2023-08-13 |
Not clear |
| Pierre R Burkhar. Acute and subacute drug-induced movement disorders. Parkinsonism & related disorders. vol 20 Suppl 1. 2014-07-11. PMID:24262159. |
motor symptoms may be isolated or part of a more extensive cerebral or systemic condition, such as the neuroleptic malignant syndrome or the serotonin syndrome. |
2014-07-11 |
2023-08-12 |
Not clear |
| Pierre R Burkhar. Acute and subacute drug-induced movement disorders. Parkinsonism & related disorders. vol 20 Suppl 1. 2014-07-11. PMID:24262159. |
the present review focuses on drug-induced movement disorders that typically develop as an acute (hours to days) or subacute (days to weeks) event, including acute dystonic reactions, akathisia, drug-induced parkinsonism, neuroleptic malignant syndrome, serotonin syndrome, parkinsonism-hyperpyrexia syndrome, drug-induced tremor, drug-induced hyperkinesias and movement disorders associated with the use of recreational drugs. |
2014-07-11 |
2023-08-12 |
Not clear |
| Annu Aggarwal, Mohit Bhat. Commonly used gastrointestinal drugs. Handbook of clinical neurology. vol 120. 2014-04-22. PMID:24365343. |
in rare instances, some of the antiemetics can precipitate life-threatening extrapyramidal reactions, neuroleptic malignant syndrome, or serotonin syndrome. |
2014-04-22 |
2023-08-12 |
Not clear |
| Outi Lapatto-Reiniluoto, Kari Raask. [Drug-associated hyperthermic syndromes]. Duodecim; laaketieteellinen aikakauskirja. vol 129. issue 24. 2014-02-20. PMID:24471206. |
drug-associated hyperthermic syndromes include the serotonin syndrome, neuroleptic malignant syndrome, neuroleptic-induced catatonia, anticholinergic syndrome, sympatomimetic syndrome and malignant hyperthermia. |
2014-02-20 |
2023-08-12 |
Not clear |
| O Joseph Bienvenu, Karin J Neufeld, Dale M Needha. Treatment of four psychiatric emergencies in the intensive care unit. Critical care medicine. vol 40. issue 9. 2012-11-28. PMID:22732295. |
to review the diagnosis and management of four selected psychiatric emergencies in the intensive care unit: agitated delirium, neuroleptic malignant syndrome, serotonin syndrome, and psychiatric medication overdose. |
2012-11-28 |
2023-08-12 |
Not clear |
| Shiau-Shian Huang, Hsin-Yu Yang, Yu-Chen Lin, Chin-Hong Cha. Low-dose venlafaxine-induced severe rhabdomyolysis: a case report. General hospital psychiatry. vol 34. issue 4. 2012-11-21. PMID:22459996. |
however, venlafaxine overdose has been reported with severe complications such as seizure, ventricular tachycardia, serotonin syndrome, neuroleptic malignant syndrome and rhabdomyolysis. |
2012-11-21 |
2023-08-12 |
Not clear |
| Paul J Perry, Courtney A Wilbor. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 24. issue 2. 2012-09-06. PMID:22563571. |
serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management. |
2012-09-06 |
2023-08-12 |
Not clear |
| Paul J Perry, Courtney A Wilbor. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 24. issue 2. 2012-09-06. PMID:22563571. |
serotonin syndrome (ss) and neuroleptic malignant syndrome (nms) are uncommon but potentially life-threatening adverse reactions associated with psychotropic medications. |
2012-09-06 |
2023-08-12 |
Not clear |
| Michael A Darrac. Comment: Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool. The Annals of pharmacotherapy. vol 46. issue 4. 2012-08-01. PMID:22414789. |
comment: neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool. |
2012-08-01 |
2023-08-12 |
Not clear |
| Hossein Sanaei-Zade. Comment: Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool. The Annals of pharmacotherapy. vol 46. issue 4. 2012-08-01. PMID:22414792. |
comment: neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool. |
2012-08-01 |
2023-08-12 |
Not clear |